Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/19/2013 | US8586332 Method for producing oligopolysaccharides |
11/19/2013 | US8586102 Germicidal composition |
11/19/2013 | US8586083 Gastroretentive drug delivery system comprising an extruded hydratable polymer |
11/19/2013 | US8586066 Topical antifungal composition |
11/19/2013 | US8586057 Enterohemorrhagic Escherichia coli vaccine |
11/19/2013 | CA2707418C Inhibitors of human immunodeficiency virus replication |
11/19/2013 | CA2707235C Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
11/19/2013 | CA2645110C Pharmaceutical composition for external use |
11/19/2013 | CA2595889C N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids |
11/19/2013 | CA2592366C Recombinant foot and mouth disease vaccine |
11/19/2013 | CA2577273C Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile |
11/19/2013 | CA2532802C Antibiotic compound isolated from streptomyces sp |
11/19/2013 | CA2497582C Prophylaxis and treatment of infectious diseases |
11/19/2013 | CA2446620C Antiviral nucleosides |
11/19/2013 | CA2375800C Vaccine against isa virus |
11/19/2013 | CA2353866C Treatment of papillomavirus infections |
11/19/2013 | CA2305620C Method for the covalent attachment of polysaccharides to protein molecules |
11/19/2013 | CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
11/14/2013 | WO2013170165A1 Antibacterial agents |
11/14/2013 | WO2013170142A1 Solid state forms of fidaxomycin and processes for preparation thereof |
11/14/2013 | WO2013170139A1 Novel ha binding agents |
11/14/2013 | WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors |
11/14/2013 | WO2013169633A1 Antibacterial calcium-based materials |
11/14/2013 | WO2013169578A1 C-17 bicyclic amines of triterpenoids with hiv maturation inhibitory activity |
11/14/2013 | WO2013169577A1 Oral solid dosage formulation of 1,1-dimethylethyl [(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate |
11/14/2013 | WO2013169520A1 Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate |
11/14/2013 | WO2013169060A1 Composition for preventing or treating sepsis |
11/14/2013 | WO2013168965A2 Vaccine composition for preventing staphylococcus aureus infection |
11/14/2013 | WO2013168002A1 Compositions and methods for the treatment of neurological conditions |
11/14/2013 | WO2013167707A1 Composition for the treatment or prevention of urinary tract infections and dosage form |
11/14/2013 | WO2013167635A1 Therapeutic use of indole-dihydro-imidazole derivatives |
11/14/2013 | WO2013167295A1 (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel |
11/14/2013 | WO2013167275A1 Composition for the prevention and treatment of viral infections caused by retroviruses |
11/14/2013 | WO2013166782A1 Preparation method of homopolymerized n-vinyl butyl lactam iodine with effective iodide content of 20% |
11/14/2013 | WO2013166609A1 Rotavirus-like particle production in plants |
11/14/2013 | WO2013085422A3 Antitubercular composition and method for producing same |
11/14/2013 | WO2013079586A4 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof |
11/14/2013 | WO2012161755A9 Antagonism of the vip signaling pathway |
11/14/2013 | WO2012149608A8 Prenylated hydroxystilbenes |
11/14/2013 | US20130303790 Pseudopolymorphic Forms Of A HIV Protease Inhibitor |
11/14/2013 | US20130303586 Oligonucleotide compositions with enhanced efficiency |
11/14/2013 | US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
11/14/2013 | US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors |
11/13/2013 | EP2662371A1 (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel |
11/13/2013 | EP2662092A1 Method for selecting patient to be given drug for treating septicemia |
11/13/2013 | EP2662086A1 Composition for the treatment or prevention of urinary tract infections and dosage form |
11/13/2013 | EP2662084A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
11/13/2013 | EP2662081A1 Therapeutic use of indole-dihydro-imidazole derivatives |
11/13/2013 | EP2661441A1 Process for preparation of caspofungin acetate and intermediates |
11/13/2013 | EP2661440A2 Methods for preparation of glycosphingolipids and uses thereof |
11/13/2013 | EP2661437A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS |
11/13/2013 | EP2661253A1 Liposome formulation suitable for treating or preventing tuberculosis |
11/13/2013 | EP2374894A9 A method for producing influenza hemagglutinin multivalent vaccines |
11/13/2013 | CN103391944A Novel macrolide intermediate and novel production process |
11/13/2013 | CN103391927A Novel process for preparation of linezolid and its novel intermediates |
11/13/2013 | CN103391924A Novel antiviral compounds |
11/13/2013 | CN103391788A Inactivated poliovaccine |
11/13/2013 | CN103391778A Pharmaceutical compositions |
11/13/2013 | CN103391777A Sirtuin modulators as virus production modulators |
11/13/2013 | CN103391774A Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections |
11/13/2013 | CN103387997A Pelodiscus sinensis picornavirus complete genome sequence and applications thereof |
11/13/2013 | CN103387996A Canine parvovirus-like particles and preparation method and application thereof |
11/13/2013 | CN103387949A Scophthalmas maximus fin rot disease antagonistic bacterium and application thereof |
11/13/2013 | CN103387615A Hand-foot-and-mouth disease vaccine based on HBc and EV71 VP4, and preparation method and application thereof |
11/13/2013 | CN103387604A CD8+T cell epitope polypeptide of S1 protein of chicken IBV (Infectious Bronchitis Virus) S1 protein |
11/13/2013 | CN103387601A Anti-dengue virus (DENV) heterocyclic peptide compounds and preparing methods and uses thereof |
11/13/2013 | CN103387582A Coumarin natural product, and preparation method and application thereof |
11/13/2013 | CN103387555A Acetophenone-substituted straight-chain sesqui derivative and application thereof in inhibiting basterium drug resistance |
11/13/2013 | CN103387550A Preparation method of antibacterial anti-cancer active compound |
11/13/2013 | CN103387548A 1,2,3-triazole antifungal compounds, and preparation method and application thereof |
11/13/2013 | CN103387277A Acidic electrolyzed water and composition thereof |
11/13/2013 | CN103386137A New application of Notch intracellular domain(NICD) gene and method and drugs for improving ability of eukaryotic cells in resisting coxsachie virus B (CVB) infection |
11/13/2013 | CN103386136A Application of hydrophobic glucan in preparation of curcumin solubilizing agent and utilization method of hydrophobic glucan |
11/13/2013 | CN103386131A Pharmaceutical composition containing adenosine or derivative of adenosine |
11/13/2013 | CN103386128A Tuberculosis subunit vaccine containing unite adjuvant |
11/13/2013 | CN103386127A Method for preparing vaccine by Newcastle disease virus cultured by using chick embryo continuous cell line and bioreactor |
11/13/2013 | CN103386126A Multivalent immunogenic composition containing enterovirus antigens |
11/13/2013 | CN103386125A Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine |
11/13/2013 | CN103386118A Method for controlling organic solvent residue in thymosin alpha 1 microspheres |
11/13/2013 | CN103386117A Caspofungin preparation with low impurity content and preparation method and use thereof |
11/13/2013 | CN103386116A Compound preparation for controlling bacillary enteritis of young sea bass |
11/13/2013 | CN103386113A Traditional Chinese medicine composition, extractive and preparation for treating swine transmissible gastroenteritis and applications of Chinese medicine composition, extractive and preparation |
11/13/2013 | CN103386107A Decoction for treating carbuncle-abscess swell and pain |
11/13/2013 | CN103386104A Traditional Chinese medicine composite for curing erysipelas and preparation method thereof |
11/13/2013 | CN103386100A Autumn diarrhea paste |
11/13/2013 | CN103386081A Traditional Chinese medicine preparation for curing respiratory tract infection in clinical nursing |
11/13/2013 | CN103386076A Mucosa nursing antibacterial gel composition and application thereof |
11/13/2013 | CN103386060A Medicament for treating onychomycosis, and preparation method thereof |
11/13/2013 | CN103386059A Chinese medicine lotion for treating cat ringworm, and preparation method thereof |
11/13/2013 | CN103386058A Medicament for treating tinea cruris and preparation method |
11/13/2013 | CN103386047A Chinese medicine decoction for treating verruca plana |
11/13/2013 | CN103386041A Honeysuckle, Chinese gall, realgar and dayflower cream for treating condyloma acuminata |
11/13/2013 | CN103386039A Medicine for degrading transaminase and liver virus and preparation method thereof |
11/13/2013 | CN103386034A Compound beriberi spraying agent |
11/13/2013 | CN103386022A Chinese medicine composition for treating tuberculous pleurisy |
11/13/2013 | CN103386020A Traditional Chinese medicine food for treating pruritus |
11/13/2013 | CN103386010A Medicine used for treating sore and ulcer disease and preparation method thereof |
11/13/2013 | CN103385999A Chinese medicine composition for treating acute mastitis |
11/13/2013 | CN103385998A Traditional Chinese medicine preparation used for treating infantile dysentery |